Eye
Medicines for Retinoblastoma
A rare eye cancer affecting young children, where an unusual white reflection in the eye (in photos) or a squint is a key sign — and where early treatment is often very successful.
Education and reference only. This explains which medicines are used and why, in plain language — it deliberately contains no doses and is not a substitute for advice from your doctor or pharmacist. Always discuss your own treatment with a qualified clinician, and check the BNF and the product labelling for prescribing detail.
Quick answer
What is Retinoblastoma?
Retinoblastoma is a rare type of eye cancer that affects the retina (the light-sensitive layer at the back of the eye). It occurs almost always in young children, usually under the age of five, and is one of the most common eye cancers of childhood, though it is rare overall.
- How it is treated: Retinoblastoma is diagnosed and treated by specialist children’s eye cancer teams (in specialist centres), and the outlook is often very good, particularly with early diagnosis; the key for families is awareness of the signs and prompt checking.
- Self-care: The key for families is awareness of the signs of retinoblastoma and prompt checking: a white reflection or glow in a child’s pupil (often noticed in flash photographs), a new squint, or other eye or vision changes should be checked promptly by a GP or optician.
- When to seek help: See a GP or optician promptly if you notice a white reflection or glow in a child’s pupil (including in flash photographs, where the affected pupil looks white instead of red-eye), a new squint, a change in the colour of the iris, a persistently red or swollen eye without infection, or a deterioration in a child’s vision — so retinoblastoma can be checked.
What it is
Retinoblastoma is a rare type of eye cancer that affects the retina (the light-sensitive layer at the back of the eye). It occurs almost always in young children, usually under the age of five, and is one of the most common eye cancers of childhood, though it is rare overall. It can affect one eye or, less commonly, both eyes. In some children it is due to an inherited genetic change (which can run in families and more often affects both eyes), while in others it occurs without a family history. Because it affects young children who cannot describe visual symptoms, it is important for parents and carers to be aware of the signs. The most well-known sign is an unusual white reflection in the pupil (the black centre of the eye), which may be noticed in dim light or, characteristically, in flash photographs — where the affected pupil appears white or has a white glow, instead of the normal red-eye reflection (this white reflection is sometimes called leukocoria). Another common sign is a new squint (where the eyes do not look in the same direction). Other, less common signs can include a change in the colour of the iris (the coloured part of the eye), a red, sore, or swollen eye without infection, or a deterioration in vision. Retinoblastoma is treatable, and with modern treatment the outlook is often very good, particularly when it is diagnosed early — treatment aims to cure the cancer while, where possible, saving the eye and preserving vision. Because early diagnosis improves the outcome and the chances of saving the eye and sight, it is important that these signs — particularly a white reflection in a child’s eye (including in photos) or a new squint — are checked promptly. The key messages are that retinoblastoma is a rare childhood eye cancer, that a white reflection in the pupil (often seen in flash photos) or a new squint are key signs to check, and that early treatment is often very successful.
How it is treated
Retinoblastoma is diagnosed and treated by specialist children’s eye cancer teams (in specialist centres), and the outlook is often very good, particularly with early diagnosis; the key for families is awareness of the signs and prompt checking. If a possible sign is noticed — particularly a white reflection or glow in a child’s pupil (including in flash photographs), a new squint, or other changes in a child’s eye or vision — it should be checked promptly by a GP or optician, who can refer for specialist assessment if needed. Diagnosis is made by specialist eye examination (examining the back of the eye, sometimes under anaesthetic in young children) and imaging, which confirm the diagnosis and assess the extent. Treatment is planned by the specialist team and depends on the size, position, and extent of the tumour, whether one or both eyes are affected, and the aim of curing the cancer while, where possible, saving the eye and preserving vision. Treatments can include: chemotherapy (given in various ways, including treatments that target the eye); local treatments to the tumour (such as laser therapy, freezing/cryotherapy, or targeted radiotherapy such as plaque brachytherapy); and, in some cases (for example if the eye cannot be saved or the cancer is advanced in that eye), removal of the affected eye (with support and an artificial eye afterwards). The specific approach is individualised, aiming to balance curing the cancer with preserving sight where possible. Because some retinoblastoma is inherited, genetic testing and counselling are offered where relevant, and other family members and future children may be monitored; children treated for retinoblastoma have follow-up. With modern treatment, the outlook is often very good, especially when the cancer is found early. The key messages for families are awareness and prompt action: a white reflection in a child’s pupil (particularly noticed in flash photos), a new squint, or other eye changes should be checked promptly, as early diagnosis improves the outcome and the chances of saving the eye and sight. The reassuring message is that retinoblastoma, though a serious cancer, is treatable and often has a very good outlook, particularly with early diagnosis and specialist treatment.
For this condition, these medicines
Medicine classes used for Retinoblastoma
Each links to a full, dose-free guide — what it is, how it works, who can and cannot use it, side effects, interactions and FAQs.
Beyond medication
Lifestyle and self-care
The key for families is awareness of the signs of retinoblastoma and prompt checking: a white reflection or glow in a child’s pupil (often noticed in flash photographs), a new squint, or other eye or vision changes should be checked promptly by a GP or optician. For families with a history of retinoblastoma, genetic advice and monitoring of children are offered. Early diagnosis improves the outcome.
When to get help
When to see a doctor
See a GP or optician promptly if you notice a white reflection or glow in a child’s pupil (including in flash photographs, where the affected pupil looks white instead of red-eye), a new squint, a change in the colour of the iris, a persistently red or swollen eye without infection, or a deterioration in a child’s vision — so retinoblastoma can be checked. Early diagnosis improves the outcome.
Not sure how urgent it is? It is always OK to call NHS 111 for advice, day or night.
Answers
Retinoblastoma: frequently asked questions
What are the signs of retinoblastoma?
The most well-known sign is an unusual white reflection or glow in a child’s pupil, often noticed in flash photographs (where the affected pupil appears white instead of the normal red-eye), or in dim light. Another common sign is a new squint. Less common signs include a change in iris colour, a persistently red or swollen eye without infection, or reduced vision. These should be checked promptly.
Is retinoblastoma curable?
Retinoblastoma is treatable, and with modern specialist treatment the outlook is often very good, particularly when it is diagnosed early. Treatment (which may include chemotherapy, local treatments to the tumour, or removal of the eye in some cases) aims to cure the cancer while, where possible, saving the eye and preserving vision. Early diagnosis improves the outcome, so signs should be checked promptly.
Sources
Where this is drawn from
- NHS — Retinoblastoma
- Childhood Eye Cancer Trust (CHECT)
Related conditions
Building a patient-information or formulary resource?
We create evidence-led, dose-free clinical references and decision aids for teams.